In Vitro Blood-Brain Barrier Permeability and Cytotoxicity of an Atorvastatin-Loaded Nanoformulation Against Glioblastoma in 2D and 3D Models.
Lübtow MM, Oerter S, Quader S, Jeanclos E, Cubukova A, Krafft M, Haider MS, Schulte C, Meier L, Rist M, Sampetrean O, Kinoh H, Gohla A, Kataoka K, Appelt-Menzel A, Luxenhofer R.
Lübtow MM, et al. Among authors: haider ms.
Mol Pharm. 2020 Jun 1;17(6):1835-1847. doi: 10.1021/acs.molpharmaceut.9b01117. Epub 2020 May 7.
Mol Pharm. 2020.
PMID: 32315193